← Back to Search

Behavioural Intervention

Lifestyle Intervention for Type 2 Diabetes (RESILIENT Trial)

N/A
Recruiting
Led By Yan Du, PhD, MPH
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults aged ≥60 years
Self-reported T2D diagnosis with verification from a health report
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks and 24 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how to help older adults with Type 2 Diabetes have better physical function and quality of life.

Who is the study for?
This trial is for diverse older adults with Type 2 Diabetes who are interested in improving their physical function and quality of life. Specific eligibility criteria details were not provided, so it's best to contact the study organizers for more information.
What is being tested?
The trial is testing a multilevel lifestyle intervention adapted from proven methods. It aims to see if this approach, when implemented in senior centers, can help improve physical activity and overall well-being in older adults with Type 2 Diabetes.
What are the potential side effects?
Since the intervention involves lifestyle changes rather than medication, side effects may include muscle soreness or fatigue due to increased physical activity. However, exact side effects are not listed and would depend on individual experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I have been diagnosed with type 2 diabetes, confirmed by a health report.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks and 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks and 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Feasibility of conducting study
Secondary study objectives
Body Weight
Diastolic Blood Pressure
Glycated Hemoglobin (HbA1c)
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lifestyle intervention groupExperimental Treatment1 Intervention
The study team will assess improvements in physical function assessed by the short physical performance battery and other health-related measures (diabetes knowledge, self-efficacy, social support, physical activity, diet consumption, HbA1c, and quality of life).

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
477 Previous Clinical Trials
92,955 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,805 Previous Clinical Trials
28,194,842 Total Patients Enrolled
Yan Du, PhD, MPHPrincipal InvestigatorThe University of Texas Health Science Center at San Antonio
~10 spots leftby Dec 2025